Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Crizotinib Market Growth 2022-2028

  • LP 4768447
  • 71 Pages
  • January 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Crizotinib will have significant change from previous year. According to our (LP Information) latest study, the global Crizotinib market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Crizotinib market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Crizotinib market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Crizotinib market, reaching US$ million by the year 2028. As for the Europe Crizotinib landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Crizotinib players cover Pfizer, Beacon Pharma, Incepta Pharmaceuticals, and Drug International, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Crizotinib market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

250mg*60 Capsules

200mg*60 Capsules

250mg*28 Capsules

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

ALK Positive NSCLC

ROS1 Positive NSCLC

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Pfizer

Beacon Pharma

Incepta Pharmaceuticals

Drug International

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Crizotinib Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Crizotinib by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Crizotinib by Country/Region, 2017, 2022 & 2028

2.2 Crizotinib Segment by Type

2.2.1 250mg*60 Capsules

2.2.2 200mg*60 Capsules

2.2.3 250mg*28 Capsules

2.3 Crizotinib Sales by Type

2.3.1 Global Crizotinib Sales Market Share by Type (2017-2022)

2.3.2 Global Crizotinib Revenue and Market Share by Type (2017-2022)

2.3.3 Global Crizotinib Sale Price by Type (2017-2022)

2.4 Crizotinib Segment by Application

2.4.1 ALK Positive NSCLC

2.4.2 ROS1 Positive NSCLC

2.5 Crizotinib Sales by Application

2.5.1 Global Crizotinib Sale Market Share by Application (2017-2022)

2.5.2 Global Crizotinib Revenue and Market Share by Application (2017-2022)

2.5.3 Global Crizotinib Sale Price by Application (2017-2022)

3 Global Crizotinib by Company

3.1 Global Crizotinib Breakdown Data by Company

3.1.1 Global Crizotinib Annual Sales by Company (2020-2022)

3.1.2 Global Crizotinib Sales Market Share by Company (2020-2022)

3.2 Global Crizotinib Annual Revenue by Company (2020-2022)

3.2.1 Global Crizotinib Revenue by Company (2020-2022)

3.2.2 Global Crizotinib Revenue Market Share by Company (2020-2022)

3.3 Global Crizotinib Sale Price by Company

3.4 Key Manufacturers Crizotinib Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Crizotinib Product Location Distribution

3.4.2 Players Crizotinib Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Crizotinib by Geographic Region

4.1 World Historic Crizotinib Market Size by Geographic Region (2017-2022)

4.1.1 Global Crizotinib Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Crizotinib Annual Revenue by Geographic Region

4.2 World Historic Crizotinib Market Size by Country/Region (2017-2022)

4.2.1 Global Crizotinib Annual Sales by Country/Region (2017-2022)

4.2.2 Global Crizotinib Annual Revenue by Country/Region

4.3 Americas Crizotinib Sales Growth

4.4 APAC Crizotinib Sales Growth

4.5 Europe Crizotinib Sales Growth

4.6 Middle East & Africa Crizotinib Sales Growth

5 Americas

5.1 Americas Crizotinib Sales by Country

5.1.1 Americas Crizotinib Sales by Country (2017-2022)

5.1.2 Americas Crizotinib Revenue by Country (2017-2022)

5.2 Americas Crizotinib Sales by Type

5.3 Americas Crizotinib Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Crizotinib Sales by Region

6.1.1 APAC Crizotinib Sales by Region (2017-2022)

6.1.2 APAC Crizotinib Revenue by Region (2017-2022)

6.2 APAC Crizotinib Sales by Type

6.3 APAC Crizotinib Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Crizotinib by Country

7.1.1 Europe Crizotinib Sales by Country (2017-2022)

7.1.2 Europe Crizotinib Revenue by Country (2017-2022)

7.2 Europe Crizotinib Sales by Type

7.3 Europe Crizotinib Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Crizotinib by Country

8.1.1 Middle East & Africa Crizotinib Sales by Country (2017-2022)

8.1.2 Middle East & Africa Crizotinib Revenue by Country (2017-2022)

8.2 Middle East & Africa Crizotinib Sales by Type

8.3 Middle East & Africa Crizotinib Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Crizotinib

10.3 Manufacturing Process Analysis of Crizotinib

10.4 Industry Chain Structure of Crizotinib

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Crizotinib Distributors

11.3 Crizotinib Customer

12 World Forecast Review for Crizotinib by Geographic Region

12.1 Global Crizotinib Market Size Forecast by Region

12.1.1 Global Crizotinib Forecast by Region (2023-2028)

12.1.2 Global Crizotinib Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Crizotinib Forecast by Type

12.7 Global Crizotinib Forecast by Application

13 Key Players Analysis

13.1 Pfizer

13.1.1 Pfizer Company Information

13.1.2 Pfizer Crizotinib Product Offered

13.1.3 Pfizer Crizotinib Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Pfizer Main Business Overview

13.1.5 Pfizer Latest Developments

13.2 Beacon Pharma

13.2.1 Beacon Pharma Company Information

13.2.2 Beacon Pharma Crizotinib Product Offered

13.2.3 Beacon Pharma Crizotinib Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Beacon Pharma Main Business Overview

13.2.5 Beacon Pharma Latest Developments

13.3 Incepta Pharmaceuticals

13.3.1 Incepta Pharmaceuticals Company Information

13.3.2 Incepta Pharmaceuticals Crizotinib Product Offered

13.3.3 Incepta Pharmaceuticals Crizotinib Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Incepta Pharmaceuticals Main Business Overview

13.3.5 Incepta Pharmaceuticals Latest Developments

13.4 Drug International

13.4.1 Drug International Company Information

13.4.2 Drug International Crizotinib Product Offered

13.4.3 Drug International Crizotinib Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Drug International Main Business Overview

13.4.5 Drug International Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Crizotinib Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Crizotinib Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of 250mg*60 Capsules

Table 4. Major Players of 200mg*60 Capsules

Table 5. Major Players of 250mg*28 Capsules

Table 6. Global Crizotinib Sales by Type (2017-2022) & (K Pcs)

Table 7. Global Crizotinib Sales Market Share by Type (2017-2022)

Table 8. Global Crizotinib Revenue by Type (2017-2022) & ($ million)

Table 9. Global Crizotinib Revenue Market Share by Type (2017-2022)

Table 10. Global Crizotinib Sale Price by Type (2017-2022) & (USD/Pcs)

Table 11. Global Crizotinib Sales by Application (2017-2022) & (K Pcs)

Table 12. Global Crizotinib Sales Market Share by Application (2017-2022)

Table 13. Global Crizotinib Revenue by Application (2017-2022)

Table 14. Global Crizotinib Revenue Market Share by Application (2017-2022)

Table 15. Global Crizotinib Sale Price by Application (2017-2022) & (USD/Pcs)

Table 16. Global Crizotinib Sales by Company (2020-2022) & (K Pcs)

Table 17. Global Crizotinib Sales Market Share by Company (2020-2022)

Table 18. Global Crizotinib Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Crizotinib Revenue Market Share by Company (2020-2022)

Table 20. Global Crizotinib Sale Price by Company (2020-2022) & (USD/Pcs)

Table 21. Key Manufacturers Crizotinib Producing Area Distribution and Sales Area

Table 22. Players Crizotinib Products Offered

Table 23. Crizotinib Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Crizotinib Sales by Geographic Region (2017-2022) & (K Pcs)

Table 27. Global Crizotinib Sales Market Share Geographic Region (2017-2022)

Table 28. Global Crizotinib Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Crizotinib Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Crizotinib Sales by Country/Region (2017-2022) & (K Pcs)

Table 31. Global Crizotinib Sales Market Share by Country/Region (2017-2022)

Table 32. Global Crizotinib Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Crizotinib Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Crizotinib Sales by Country (2017-2022) & (K Pcs)

Table 35. Americas Crizotinib Sales Market Share by Country (2017-2022)

Table 36. Americas Crizotinib Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Crizotinib Revenue Market Share by Country (2017-2022)

Table 38. Americas Crizotinib Sales by Type (2017-2022) & (K Pcs)

Table 39. Americas Crizotinib Sales Market Share by Type (2017-2022)

Table 40. Americas Crizotinib Sales by Application (2017-2022) & (K Pcs)

Table 41. Americas Crizotinib Sales Market Share by Application (2017-2022)

Table 42. APAC Crizotinib Sales by Region (2017-2022) & (K Pcs)

Table 43. APAC Crizotinib Sales Market Share by Region (2017-2022)

Table 44. APAC Crizotinib Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Crizotinib Revenue Market Share by Region (2017-2022)

Table 46. APAC Crizotinib Sales by Type (2017-2022) & (K Pcs)

Table 47. APAC Crizotinib Sales Market Share by Type (2017-2022)

Table 48. APAC Crizotinib Sales by Application (2017-2022) & (K Pcs)

Table 49. APAC Crizotinib Sales Market Share by Application (2017-2022)

Table 50. Europe Crizotinib Sales by Country (2017-2022) & (K Pcs)

Table 51. Europe Crizotinib Sales Market Share by Country (2017-2022)

Table 52. Europe Crizotinib Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Crizotinib Revenue Market Share by Country (2017-2022)

Table 54. Europe Crizotinib Sales by Type (2017-2022) & (K Pcs)

Table 55. Europe Crizotinib Sales Market Share by Type (2017-2022)

Table 56. Europe Crizotinib Sales by Application (2017-2022) & (K Pcs)

Table 57. Europe Crizotinib Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Crizotinib Sales by Country (2017-2022) & (K Pcs)

Table 59. Middle East & Africa Crizotinib Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Crizotinib Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Crizotinib Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Crizotinib Sales by Type (2017-2022) & (K Pcs)

Table 63. Middle East & Africa Crizotinib Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Crizotinib Sales by Application (2017-2022) & (K Pcs)

Table 65. Middle East & Africa Crizotinib Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Crizotinib

Table 67. Key Market Challenges & Risks of Crizotinib

Table 68. Key Industry Trends of Crizotinib

Table 69. Crizotinib Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Crizotinib Distributors List

Table 72. Crizotinib Customer List

Table 73. Global Crizotinib Sales Forecast by Region (2023-2028) & (K Pcs)

Table 74. Global Crizotinib Sales Market Forecast by Region

Table 75. Global Crizotinib Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Crizotinib Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Crizotinib Sales Forecast by Country (2023-2028) & (K Pcs)

Table 78. Americas Crizotinib Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Crizotinib Sales Forecast by Region (2023-2028) & (K Pcs)

Table 80. APAC Crizotinib Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Crizotinib Sales Forecast by Country (2023-2028) & (K Pcs)

Table 82. Europe Crizotinib Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Crizotinib Sales Forecast by Country (2023-2028) & (K Pcs)

Table 84. Middle East & Africa Crizotinib Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Crizotinib Sales Forecast by Type (2023-2028) & (K Pcs)

Table 86. Global Crizotinib Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Crizotinib Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Crizotinib Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Crizotinib Sales Forecast by Application (2023-2028) & (K Pcs)

Table 90. Global Crizotinib Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Crizotinib Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Crizotinib Revenue Market Share Forecast by Application (2023-2028)

Table 93. Pfizer Basic Information, Crizotinib Manufacturing Base, Sales Area and Its Competitors

Table 94. Pfizer Crizotinib Product Offered

Table 95. Pfizer Crizotinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 96. Pfizer Main Business

Table 97. Pfizer Latest Developments

Table 98. Beacon Pharma Basic Information, Crizotinib Manufacturing Base, Sales Area and Its Competitors

Table 99. Beacon Pharma Crizotinib Product Offered

Table 100. Beacon Pharma Crizotinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 101. Beacon Pharma Main Business

Table 102. Beacon Pharma Latest Developments

Table 103. Incepta Pharmaceuticals Basic Information, Crizotinib Manufacturing Base, Sales Area and Its Competitors

Table 104. Incepta Pharmaceuticals Crizotinib Product Offered

Table 105. Incepta Pharmaceuticals Crizotinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 106. Incepta Pharmaceuticals Main Business

Table 107. Incepta Pharmaceuticals Latest Developments

Table 108. Drug International Basic Information, Crizotinib Manufacturing Base, Sales Area and Its Competitors

Table 109. Drug International Crizotinib Product Offered

Table 110. Drug International Crizotinib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 111. Drug International Main Business

Table 112. Drug International Latest Developments

List of Figures

Figure 1. Picture of Crizotinib

Figure 2. Crizotinib Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Crizotinib Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Crizotinib Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Crizotinib Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of 250mg*60 Capsules

Figure 10. Product Picture of 200mg*60 Capsules

Figure 11. Product Picture of 250mg*28 Capsules

Figure 12. Global Crizotinib Sales Market Share by Type in 2021

Figure 13. Global Crizotinib Revenue Market Share by Type (2017-2022)

Figure 14. Crizotinib Consumed in ALK Positive NSCLC

Figure 15. Global Crizotinib Market: ALK Positive NSCLC (2017-2022) & (K Pcs)

Figure 16. Crizotinib Consumed in ROS1 Positive NSCLC

Figure 17. Global Crizotinib Market: ROS1 Positive NSCLC (2017-2022) & (K Pcs)

Figure 18. Global Crizotinib Sales Market Share by Application (2017-2022)

Figure 19. Global Crizotinib Revenue Market Share by Application in 2021

Figure 20. Crizotinib Revenue Market by Company in 2021 ($ Million)

Figure 21. Global Crizotinib Revenue Market Share by Company in 2021

Figure 22. Global Crizotinib Sales Market Share by Geographic Region (2017-2022)

Figure 23. Global Crizotinib Revenue Market Share by Geographic Region in 2021

Figure 24. Global Crizotinib Sales Market Share by Region (2017-2022)

Figure 25. Global Crizotinib Revenue Market Share by Country/Region in 2021

Figure 26. Americas Crizotinib Sales 2017-2022 (K Pcs)

Figure 27. Americas Crizotinib Revenue 2017-2022 ($ Millions)

Figure 28. APAC Crizotinib Sales 2017-2022 (K Pcs)

Figure 29. APAC Crizotinib Revenue 2017-2022 ($ Millions)

Figure 30. Europe Crizotinib Sales 2017-2022 (K Pcs)

Figure 31. Europe Crizotinib Revenue 2017-2022 ($ Millions)

Figure 32. Middle East & Africa Crizotinib Sales 2017-2022 (K Pcs)

Figure 33. Middle East & Africa Crizotinib Revenue 2017-2022 ($ Millions)

Figure 34. Americas Crizotinib Sales Market Share by Country in 2021

Figure 35. Americas Crizotinib Revenue Market Share by Country in 2021

Figure 36. United States Crizotinib Revenue Growth 2017-2022 ($ Millions)

Figure 37. Canada Crizotinib Revenue Growth 2017-2022 ($ Millions)

Figure 38. Mexico Crizotinib Revenue Growth 2017-2022 ($ Millions)

Figure 39. Brazil Crizotinib Revenue Growth 2017-2022 ($ Millions)

Figure 40. APAC Crizotinib Sales Market Share by Region in 2021

Figure 41. APAC Crizotinib Revenue Market Share by Regions in 2021

Figure 42. China Crizotinib Revenue Growth 2017-2022 ($ Millions)

Figure 43. Japan Crizotinib Revenue Growth 2017-2022 ($ Millions)

Figure 44. South Korea Crizotinib Revenue Growth 2017-2022 ($ Millions)

Figure 45. Southeast Asia Crizotinib Revenue Growth 2017-2022 ($ Millions)

Figure 46. India Crizotinib Revenue Growth 2017-2022 ($ Millions)

Figure 47. Australia Crizotinib Revenue Growth 2017-2022 ($ Millions)

Figure 48. Europe Crizotinib Sales Market Share by Country in 2021

Figure 49. Europe Crizotinib Revenue Market Share by Country in 2021

Figure 50. Germany Crizotinib Revenue Growth 2017-2022 ($ Millions)

Figure 51. France Crizotinib Revenue Growth 2017-2022 ($ Millions)

Figure 52. UK Crizotinib Revenue Growth 2017-2022 ($ Millions)

Figure 53. Italy Crizotinib Revenue Growth 2017-2022 ($ Millions)

Figure 54. Russia Crizotinib Revenue Growth 2017-2022 ($ Millions)

Figure 55. Middle East & Africa Crizotinib Sales Market Share by Country in 2021

Figure 56. Middle East & Africa Crizotinib Revenue Market Share by Country in 2021

Figure 57. Egypt Crizotinib Revenue Growth 2017-2022 ($ Millions)

Figure 58. South Africa Crizotinib Revenue Growth 2017-2022 ($ Millions)

Figure 59. Israel Crizotinib Revenue Growth 2017-2022 ($ Millions)

Figure 60. Turkey Crizotinib Revenue Growth 2017-2022 ($ Millions)

Figure 61. GCC Country Crizotinib Revenue Growth 2017-2022 ($ Millions)

Figure 62. Manufacturing Cost Structure Analysis of Crizotinib in 2021

Figure 63. Manufacturing Process Analysis of Crizotinib

Figure 64. Industry Chain Structure of Crizotinib

Figure 65. Channels of Distribution

Figure 66. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390